FAVERO, GAIA
 Distribuzione geografica
Continente #
NA - Nord America 6.583
AS - Asia 3.374
EU - Europa 3.017
SA - Sud America 679
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 13.724
Nazione #
US - Stati Uniti d'America 6.497
SG - Singapore 1.135
CN - Cina 1.130
UA - Ucraina 755
PL - Polonia 621
BR - Brasile 561
HK - Hong Kong 458
DE - Germania 414
IT - Italia 331
FI - Finlandia 205
VN - Vietnam 185
GB - Regno Unito 146
FR - Francia 131
TR - Turchia 129
IE - Irlanda 124
IN - India 123
RU - Federazione Russa 121
AR - Argentina 55
BD - Bangladesh 45
CA - Canada 37
MX - Messico 31
SE - Svezia 30
ID - Indonesia 24
BE - Belgio 23
ES - Italia 22
CZ - Repubblica Ceca 20
IQ - Iraq 20
JP - Giappone 19
AT - Austria 17
NL - Olanda 16
ZA - Sudafrica 16
CO - Colombia 14
EC - Ecuador 13
PK - Pakistan 13
KR - Corea 12
LT - Lituania 11
SA - Arabia Saudita 11
CL - Cile 9
PY - Paraguay 9
AE - Emirati Arabi Uniti 8
MA - Marocco 8
VE - Venezuela 8
AU - Australia 7
AZ - Azerbaigian 7
EU - Europa 7
IL - Israele 7
KE - Kenya 7
EG - Egitto 6
NP - Nepal 6
TN - Tunisia 6
UZ - Uzbekistan 6
CH - Svizzera 5
JM - Giamaica 5
JO - Giordania 5
KZ - Kazakistan 5
PE - Perù 5
TT - Trinidad e Tobago 5
UY - Uruguay 5
AL - Albania 4
HU - Ungheria 4
LA - Repubblica Popolare Democratica del Laos 4
BG - Bulgaria 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
LB - Libano 3
PS - Palestinian Territory 3
AM - Armenia 2
CR - Costa Rica 2
EE - Estonia 2
IR - Iran 2
MK - Macedonia 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
IM - Isola di Man 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
LY - Libia 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 13.721
Città #
Fairfield 756
Warsaw 619
Woodbridge 540
Jacksonville 526
Singapore 525
Ashburn 519
Hong Kong 451
Houston 419
Ann Arbor 409
Seattle 339
Wilmington 292
Cambridge 290
Beijing 281
Chandler 245
Princeton 224
Dallas 173
Nanjing 163
New York 163
Los Angeles 122
Dublin 120
Brescia 105
Istanbul 104
The Dalles 88
Helsinki 86
Munich 75
Dearborn 74
Des Moines 65
Ho Chi Minh City 63
Moscow 60
Nanchang 50
São Paulo 49
Hebei 48
Milan 48
Buffalo 47
San Diego 46
San Francisco 46
Changsha 45
Shenyang 45
Redondo Beach 42
Hanoi 38
Shanghai 38
Jiaxing 37
Jinan 33
Boardman 32
Chicago 32
Tianjin 30
Dong Ket 28
Hangzhou 24
Brussels 23
Brooklyn 22
Turku 22
London 19
Tokyo 19
Kunming 18
Santa Clara 17
Atlanta 16
Lappeenranta 16
Montreal 16
Norwalk 16
Rio de Janeiro 16
Grafing 14
Jakarta 14
Mexico City 14
Brno 13
Nuremberg 13
Phoenix 13
Stockholm 13
Belo Horizonte 12
Denver 12
Haikou 12
Ningbo 12
Rome 11
Baghdad 10
Charlotte 10
Chennai 10
Frankfurt am Main 10
Johannesburg 10
Kyiv 10
Manchester 10
Orange 10
Toronto 10
Zhengzhou 10
Guangzhou 9
Indianapolis 9
Lanzhou 9
Amsterdam 8
Brasília 8
Buenos Aires 8
Council Bluffs 8
Curitiba 8
Dhaka 8
Poplar 8
Porto Alegre 8
Pune 8
Vienna 8
Düsseldorf 7
Haiphong 7
Lancaster 7
New Delhi 7
Taiyuan 7
Totale 9.269
Nome #
Role of heme oxygenase in modulating endothelial function in mesenteric small resistance arteries of spontaneously hypertensive rats. 295
Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease 254
Taurine supplementation alleviates puromycin aminonucleoside damage by modulating endoplasmic reticulum stress and mitochondrial-related apoptosis in rat kidney 254
NF-kB- A key factor in atherogenesis and atheroprogression. 239
Perspective: Mitochondria-ER Contacts in Metabolic Cellular Stress Assessed by Microscopy 202
AQP1 expression in human gingiva and its correlation with periodontal and peri-implant tissue alterations. 195
Anticontractile activity of perivascular fat in obese mice and the effect of long-term treatment with melatonin. 195
A comparative pilot study of two dental implant metals in a pig model 183
Hypertrophic remodeling of subcutaneous small resistance arteries in patients with Cushing's syndrome. 183
Resveratrol and Sirt 1 activators for the treatment of aging and age-related diseases 180
Sirtuins, aging, and cardiovascular risks 178
Aging and vascular dysfunction: beneficial melatonin effects 176
Aging and vascular dysfunction: beneficial melatonin effects. 164
Effect of long-term treatment with melatonin on vascular markers of oxidative stress/inflammation and on the anticontractile activity of perivascular fat in aging mice 163
Angiotensin receptor blockers improve insulin signaling and prevent microvascular rarefaction in the skeletal muscle of spontaneously hypertensive rats. 161
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 158
Melatonin reduces obesity and restores adipokine patterns and metabolism in obese (ob/ob) mice 153
Acute mercury exposition of virgin, pregnant, and lactating rats: Histopathological kidney and liver evaluations 152
Melatonin as an Anti-Inflammatory Agent Modulating Inflammasome Activation 147
Synapsin III alterations in Parkinson's disease 147
Dietary Melatonin Supplementation Could Be a Promising Preventing/Therapeutic Approach for a Variety of Liver Diseases 147
Changes in extracellular matrix in subcutaneous small resistance arteries of patients with essential hypertension 145
Impact of melatonin on skeletal muscle and exercise 143
Sodium-DNA for Bone Tissue Regeneration: An Experimental Study in Rat Calvaria 143
Oral supplementation of melatonin protects against lupus nephritis renal injury in a pristane-induced lupus mouse model 141
Nicotine-Induced Morphological Changes in Rat Aorta: The Protective Role of Melatonin 139
Sirtuin 6 nuclear localization at cortical brain level of young diabetic mice: An immunohistochemical study 135
Melatonin: Protection against age-related cardiac pathology 135
A carnosine analog with therapeutic potentials in the treatment of disorders related to oxidative stress 135
Protective effects of quercetin treatment in a pristane-induced mouse model of lupus nephritis 134
Atherosclerosis and Current Anti-Oxidant Strategies for Atheroprotection 131
Mitochondrial dysfunction in skeletal muscle of a fibromyalgia model: The potential benefits of melatonin 131
Melatonin and its atheroprotective effects: A review. 130
Melatonin sirtuin1-dependent mechanism of action in an hypercholesterolemic animal model 128
Growth factors, CD34 positive cells, and fibrin network analysis in concentrated growth factors fraction 127
Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet 125
Attenuation of ultraviolet A-induced alterations in NIH3T3 dermal fibroblasts by melatonin. 123
Vascular aging and melatonin beneficial effects 123
Anti-atherosclerotic properties of wild rice in low-density lipoprotein receptor knockout mice: The gut microbiome, cytokines, and metabolomics study 123
Synapsin III Alteration in Parkinson's disease 119
Collagen subtypes in the tunica adventitia of subcutaneous small resistance arteries of patients with primary aldosteronism. 117
Thymus and aging: morphological, radiological, and functional overview. 116
Endothelin-1 as a potential marker of melatonin's therapeutic effects in smoking-induced vasculopathy. 115
Synapsin III Alteration in Parkinson's disease 115
Melatonin Pharmacological Blood Levels Increase Total Antioxidant Capacity in Critically Ill Patients 114
Anti-atherogenic diets: observations from mouse models. 114
Fibronectin but not laminin content is increased in the tunica media of subcutaneous small resistance arteries of patients with essential hypertension 112
Upregulation of HO-1 accompanied by an increase in adiponectin improves cardiac function via Pamp-Penos pathway in spontaneously hypertensive rats. 112
Obesity-related dysfunction of the aorta and prevention by melatonin treatment in ob/ob mice 111
Melatonin reduces excitotoxic blood-brain barrier breakdown in neonatal rats 111
Beneficial effects of melatonin on nicotine-induced vasculopathy 110
Endothelial and vascular smooth muscle cell dysfunction mediated by cyclophylin A and the atheroprotective effects of melatonin 110
Sirtuin 6 localization at cortical brain level of young diabetic mice. 109
Oral supplementation of melatonin protects against fibromyalgia-related skeletal muscle alterations in reserpine-induced myalgia rats 109
Vascular oxidative stress-induced senescence is minimized by melatonin intake in Apo-E deficient mice 107
Does melatonin protect dermis fibroblasts from UVA radiations? 107
Effect of long-term treatment with melatoni against obesity related dysfunctions in obese mice. 107
Atheroslerosis and current anti-oxidant strategies for atheroprotection 107
Vascular aging and melatonin beneficial effects 107
Aluminium exposure induces Alzheimer's disease-like histopathological alterations in mouse brain 105
Changes of collagen subtypes in the tunica adventitia of subcutaneous small resistance arteries of patients with primary aldosteronism 105
Endothelium and its alterations in cardiovascular diseases: life style intervention. 105
Mitochondrial and metabolic dysfunction in renal convoluted tubules of obese mice: protective role of melatonin 105
Antitumor activity of melatonin in a mouse model of human prostate cancer: relationship with hypoxia signaling. 104
Melatonin efficacy in obese leptin-deficient mice heart 103
Browning of Adipose Tissue and Sirtuin1 Involvement. 103
Endoplasmic reticulum stress in the endothelium: a contribution to atherosusceptibility 102
Melatonin in plant-based food: implications for human health. 101
Metabolic sindrome and melatonin: a tool for prevent obesity-associated abnormalities. 100
Melatonin Modulation of Sirtuin-1 Attenuates Liver Injury in a Hypercholesterolemic Mouse Model 100
A comparison of melatonin and α-lipoic acid in the induction of antioxidant defences in L6 rat skeletal muscle cells 97
Promising antineoplastic actions of melatonin 97
Role of Apolipoprotein E in liver aging protection 95
EET agonist improves cardiac energy metabolism and heart function by regulating fatty acid oxidation and oxidative stress in infarcted myocardium. 95
Vascular cell dysfunctions: a possible atheroprotective role of melatonin 94
Contenuto di fibronectina e laminina nella tonaca media delle piccole arterie di resistenza sottocutanee in pazienti con ipertensione essenziale. 93
Site-specific heme oxygenase-1 expresion into adipocytes leads to increase in EET levels reduced adiposity and blood pressure in obese mice. 93
Beneficial effects of melatonin on apolipoprotein-e knockout mice by morphological and18f-fdg pet/ct assessments 93
Effect of long-term treatment with melatonin against obesity related dysfunctions in obese mice. 92
Melatonin limited early atherosclerotic changes in ApoE null mice 91
Vascular endothelial cells and dysfunctions: role of melatonin 91
CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high-fat diet by reprogramming adipocyte phenotype. 90
Modificazioni dei sottotipi di collagene nell’avventizia di arterie di resistenza sottocutanee in pazienti affetti da iperaldosteronismo primitivo. 90
Endothelial and neural cell marker alterations in dorsal root ganglia during inflammatory pain. 89
Melatonin impact on cyclosporine-induced liver damage: an update 89
Adipocyte specific HO-1 gene therapy is effective in antioxidant treatment of insulin resistance and vascular function in an obese mice model 87
Development of NASH in Obese Mice is Confounded by Adipose Tissue Increase in Inflammatory NOV and Oxidative Stress 86
Biomaterials in maxillofacial surgery: membranes and grafts 85
Metabolic syndrome and beneficial vascular effect of melatonin. 84
Heme oxygenase-1 mediated PPARδ improves cardiac fibrosis and inflammation in SCID mice via induction of T Reg cells. 84
Protective role of melatonin against obesity-associated vascular dysfunctions. 84
Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in PGC1α-HO-1-PGC1α-mitochondrial signaling 84
Melatonin promotes beneficial Mitofusin 2 in obese mice kidney. 83
Fibronectin and laminin content in the tunica media of subcutaneous small resistance arteries of patients with essential hypertension. 82
STRESS PROTEINS IN EXPERIMENTAL NEPHROTOXICITY: A TEN YEAR EXPERIENCE 79
CYP2J2 targeting to endothelial cells attenuates adiposity and vascular dysfunction in mice fed a high fat diet by reprogramming adipocyte phenotype. 79
Leptin-deficient obese mice: a multi-organ stress model rescued by melatonin 78
Melatonin reduces ER stress and steatosis in liver of obese mice: a microscopic appraisal 77
HO-1 involvement in iron homeostasis in liver of obese mice. 77
Melatonin and obesity-associated cardiovascular alterations 76
Totale 12.293
Categoria #
all - tutte 66.595
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 66.595


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.179 0 0 0 0 0 197 54 215 198 259 173 83
2021/2022936 67 131 16 81 12 46 44 62 38 128 94 217
2022/2023761 136 20 13 53 87 200 3 79 99 3 29 39
2023/2024833 55 24 63 54 39 135 24 35 234 21 12 137
2024/20252.249 22 19 25 239 256 153 218 66 272 158 468 353
2025/20262.665 429 589 467 597 508 75 0 0 0 0 0 0
Totale 14.031